Malignant pleural mesothelioma: clinicopathologic and survival characteristic in a consecutive series of 40 patients Source: Annual Congress 2009 - Preoperative functional assessment and surgery for malignant diseases Year: 2009
Malignant pleural mesothelioma clinical aspects and survival in 93 cases Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010
Malignant mesothelioma: evaluation of 67 cases Source: Eur Respir J 2001; 18: Suppl. 33, 534s Year: 2001
Determinants of survival in patients with malignant pleural mesothelioma (MPM) managed at a single institution in Liguria, Italy Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma Year: 2018
Salvage treatment in patients with recurrent or resistant malignant pleura mesothelioma. A retrospective study from tertiary oncology department Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016
Survival time in patients with malignant pleural mesothelioma Source: Annual Congress 2007 - Rare tumours, risk factors and epidemiology in thoracic oncology Year: 2007
Malignant mesothelioma: a description of 56 cases Source: Eur Respir J 2005; 26: Suppl. 49, 146s Year: 2005
The association between pleural fluid exposure and survival in malignant pleural mesothelioma: a retrospective cohort study in 761 patients Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications Year: 2020
Malignant pleural mesothelioma (MPM): clinical presentation, complications and survival Source: Eur Respir J 2002; 20: Suppl. 38, 272s Year: 2002
Malignant pleural mesothelioma:a 16-year, single centre experience Source: International Congress 2017 – Pleural and mediastinal malignancies Year: 2017
Time to diagnosis and time to therapy in patients with malignant pleural mesothelioma (MPM) compared to patients with lung cancer in Denmark 2007 to 2011. A quality assurance analysis Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions Year: 2012
Malignant pleural mesothelioma stage III and IV: Retrospective analysis of ten years in a central hospital Source: Annual Congress 2012 - Clinical issues in malignant pleural effusions Year: 2012
Prognostic factors and survival in malignant pleural mesothelioma at a large tertiary referral center in Turkey Source: Annual Congress 2012 - Clinical issues in malignant pleural effusions Year: 2012
Ultrasound assisted Tru-Cut biopsy of pleural tumors: a prospective analysis of 62 consecutive cases in a high incidence area for malignant mesothelioma Source: Eur Respir J 2002; 20: Suppl. 38, 594s Year: 2002
Pleurectomy/decortication for malignant pleural mesothelioma: a single-centre experience. Source: Virtual Congress 2020 – Thoracic surgery: developments in diagnostics and outcomes Year: 2020
Malignant pleural mesothelioma (MPM) – 5 years of experience Source: Eur Respir J 2006; 28: Suppl. 50, 91s Year: 2006
Prognostic value of treatment outcomes patients with malignant pleural mesothelioma Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010
Malignant and non-malignant asbestos-related pleural and lung disease: 10-year follow-up study Source: Eur Respir J 2004; 24: Suppl. 48, 527s Year: 2004
Epidemiology, histology and thoracoscopic findings in malignant pleural mesothelioma (MPM) as second tumour in a single-centre cohort Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions Year: 2010